Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3077

Actual shortage: 235 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2817 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 583
CEFEPIME FOR INJECTION 2G POWDER FOR SOLUTION Actual shortage 2017-03-12 2017-10-05 698
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2019-07-31 2019-08-02 90341
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2019-12-05 2020-02-18 100265
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2021-06-11 2021-08-06 140772
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2021-09-17 2021-10-25 145822
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2024-02-23 2024-03-01 220444
APO-CEFEPIME 2G POWDER FOR SOLUTION Actual shortage 2024-05-24 2024-06-07 228807
APO-LOPERAMIDE 2MG TABLET Actual shortage 2017-03-10 2017-10-05 372

Showing 1681 to 1700 of 3077

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VORICONAZOLE 200MG TABLET Discontinued 2018-09-08 2018-09-15 60858
IBUPROFEN LIQUID GEL CAPSULES 200MG CAPSULE Discontinued 2019-01-03 2019-01-03 71095
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-01-03 2019-01-03 71112
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-07-22 71439
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-07-12 2019-07-13 89135
APO-PROPRANOLOL 20MG TABLET Discontinued 2017-03-13 2017-03-13 1163
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-ATORVASTATIN 20MG TABLET Discontinued 2018-09-07 2019-02-13 60279
APO-CITALOPRAM 20MG TABLET Discontinued 2018-09-07 2019-02-13 60393
APO-ENALAPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-19 60465
APO-ESCITALOPRAM 20MG TABLET Discontinued 2018-09-07 2018-09-15 60471
APO-FUROSEMIDE 20MG TABLET Discontinued 2018-09-07 2018-09-15 60506
APO-LISINOPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-PAROXETINE 20MG TABLET Discontinued 2018-09-08 2018-09-15 60684
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045

Showing 161 to 180 of 356